250results about How to "Eliminate symptoms" patented technology

The present invention relates to traditional Chinese medicine for treating coronary heart disease and stenocardia is made from (by wt.%) salvia root 50-97%, notoginseng 2-48% and borneol 0.2-3%, in which the salvia root and notoginseng and hot extracted with water, then filtering, concentrating, alcohol precipitating, standing still, recovering ethyl alcohol, concentrating, into extractum, further blended with borneol and adjuvant polyglycol-6000 to form into product.

The present invention is directed to a combination treatment of an opioid antagonist e.g., naltrexone and a second compound selected from the group consisting of a GABA B agonist, an NMDA antagonist, a serotonin antagonist, and a cannabinoid antagonist is the key to the successful treatment of a brain reward system disorder. A brain reward system, include but are not limited, to pathological gambling, compulsive alcohol consumption, compulsive over-eating and obesity, compulsive smoking, and drug addiction. The compounds and methods of the present invention effectively reduce the cravings, withdrawal symptoms and negative drug side effects associated with a monotherapy. As such, patient compliance is greatly increased, thereby decreasing relapse of a brain reward system disorder.

The invention provides a method, and dosage form therefor, of treating impaired motor function associated with Parkinson's disease, anti-Parkinson's drug treatment, e.g. L-Dopa therapy, and/or dementia associated with Parkinson's disease. The invention includes the combined administration of an NMDA receptor antagonist and an antidepressant, e.g., the combination of amantadine and citalopram or venlafaxine, or an NMDA receptor antagonist and an anxiolytic agent, e.g., amantadine and buspirone or trazodone, for the amelioration of undesired tremors, akinesia, dyskinesia, or bradykinesia associated with one or more different disorders or diseases. The drugs can be included in a single dosage form. One embodiment includes a combination dosage form containing each drug in controlled release forms. Another embodiment includes a combination dosage form providing a controlled release of an NMDA receptor antagonist and a rapid release of a neuroactive agent after administration to a subject.

The invention discloses a five-element energy balance moxa stick and a manufacturing method thereof. The five-element energy balance moxa stick comprises a moxa layer (1), a tubular medicine layer (2) and a medicine column layer (3), wherein the tubular medicine layer (2) is located in the moxa layer (1), and the medicine column layer is located outside the moxa layer. The tubular medicine layer is formed by connecting a heart balancing medicine column (2-1), a lung balancing medicine column (2-2), a kidney balancing medicine column (2-3), a liver balancing medicine column (2-4) and a spleen balancing medicine column (2-5) in series; the medicine column layer comprises a heart balancing medicine column layer (3-1), a lung balancing medicine column layer (3-2), a kidney balancing medicine column layer (3-3), a liver balancing medicine column layer (3-4) and a spleen balancing medicine column layer (3-5). According to the five-element energy balance moxa stick, the five medicine columns correspond to the five elements, the five elements correspond to five internal organs of the human body, five-element energy balance of the heart, lung, kidney, liver and spleen can be ensured through the five medicine columns, various symptoms caused by sub-health are eliminated, and the purpose of body building is achieved.

The present invention relates to an oral formulation comprising a hyaluronic acid-phospholipid complex, and to use of a hyaluronic acid-phospholipid complex for the manufacture of a joint function-improving and protecting agent for oral administration which can alleviate the arthritic symptoms in patients with arthritic conditions, increase the concentration of hyaluronic acid in synovial fluid, improve the lubrication of joints, as well as maintain and enhance the normal functions of joints.

Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer.

The invention relates to the use of flumazenil in developing a drug used for the sequential administration of small quantities of flumazenil at short intervals, until a therapeutically effective quantity is administered to treat alcohol dependence.

The invention discloses a thrombus removing device capable of preventing damage on an inner wall of a blood vessel. The thrombus removing device of the invention comprises an outer support sleeving device and an internal removing device; the outer support sleeving device comprises a metal sleeve and an outer sleeving tube; an infrared detection device is arranged on an end surface of the metal sleeve which faces a cutting device; the internal cleaning device comprises a first thrombus channel, a second thrombus channel and the cutting device; the cutting device comprises blade support strips, blades, a pin roll, an air cylinder, a rubber sleeve and projected strips; an internal removing device of the thrombus removing device supports one side of the inner wall of the blood vessel with the thrombus through the outer support sleeving device before working to prevent the inner wall of the blood vessel from being scratched during a removing process; a motor drives the second thrombus channel to rotate and the blade support stripes expand through the air cylinder; and infrared detection device on the outer support sleeving device can detect an opening position of the blades. The thrombus removing device capable of preventing damage on inner wall of blood vessel can provide convenience to medical staff to control the blades not to go beyond a scratching-proof fillet and guarantees that the inner wall of the blood vessel is not damaged while the vessel is unblocked.

The invention relates to a medicament for treating gout, in particular to a traditional Chinese medicine formula for treating the gout, which is prepared by taking plant Chinese herbal medicines as raw materials. The traditional Chinese medicine formula is prepared by the following active pharmaceutical ingredients by weight: 20-30g of glabrous greenbrier rhizome, 20-30g of coix seed, 15-25g of giant knotweed rhizome, 10-20g of Mongolian dandelion herb, 10-20g of oriental waterplantain rhizome, 10-20g of sevenlobed yam rhizome, 5-15g of red paeony root, 5-15g of peach seed, 5-15g of amur corktree bark and 5-15g of Indian iphigenia bulb. All the medicines are compatible and complement mutually, thereby having the effects of clearing heat-toxin, promoting blood circulation for removing blood stasis, eliminating carbuncles, removing swelling, dredging channels, relieving pain, promoting urination, relieving swelling, strengthening spleen for eliminating dampness, relieving rigidity of muscles, removing paralysis and the like, realizing the synergism of medicine effects, treating both manifestation and root cause of the disease, having no side effects, promoting the excretion of uric acid in a human body, achieving the effects of eliminating symptoms and reducing the blood uric acid, and effectively treating the symptoms of the gout.

The invention discloses a traditional Chinese medicine prescription used for treating heart qi deficiency syndrome type chest stuffiness and cardialgia. The traditional Chinese medicine prescription is characterized by comprising, by weight, 10-15 parts of dragon bone, 20-30 parts of oyster, 10-15 parts of ophiopogon root, 4-6 parts of dried ginger, 20-30 parts of dried rehmannia, 20-30 parts of salvia, 20-30 parts of astragalus, 7-10 parts of goldthread root, 20-30 parts of white peony root, 4-6 parts of licorice root, 7-10 parts of schizandrae, 7-10 parts of arborvitae seed, 20-30 parts of spiny jujube, 9-10 parts of donkey-hide glue, 7-10 parts of ginseng, 15-24 parts of tortoise shell, 7-10 parts of amomum, 10-15 parts of turtle shell, 14-20 parts of poria cocos and 7-10 parts of cassia twig. The traditional Chinese medicine prepared by organically combining the preceding raw materials has the functions of quickening blood and removing meridian obstruction, tonifying qi and warming channels, rectifying qi and eliminating phlegm, harmonizing blood and dredging impediment, supplementing heart qi and the like, and as is shown clinically, the effective rate reaches 88%.

The invention discloses a traditional Chinese medicine for treating amblyopia eye diseases and relates to a preparation prepared from the traditional Chinese medicines as raw materials. The traditional Chinese medicine is prepared from semen cassiae, radix paeoniae alba, salvia miltiorrhiza, medlar, tuckahoe, dendrobe, kudzuvine root, tuber of dwarf lilyturf, tribulus terrestris, adenophora tetraphylla, yam, forsythia core, motherwort fruit, lophatherum gracile, antelope horn powder, glabrousleaf pittosporum seed and fructus psoraleae. The clinical use result of the traditional Chinese medicine shows that the prescription has the functions of enhancing the capability of supplying blood to caridiac muscle, promoting the blood circulation and improving the development process of eye parts of patients and promoting the repair of optic nerve and retina cells as well as the efficacies of nourishing the kidney, nourishing the liver and improving acuity of vision; the prescription can be used for treating amblyopia, hyperopia, yellow spot and other diseases caused by various reasons; and the traditional Chinese medicine has unique formula and curative effect, especially has remarkable effects for infants and juvenile patients and can ensure that the symptoms of the patients are eliminated and the visions of the patients are recovered.

The present invention relates to gene expression signatures that predict response and resistance to targeted therapy and immunotherapy.

A Chinese medicine in the form of ointment for treating spur (hyperosteogeny) and eczema is prepared from realgar, baked alum and borneol through grinding and mixing with vaseline. It has high cure rate (80-90%).

A method of vibration treatment in at least one nasal cavity of a human subject is provided. The method comprises the steps of: inserting a first stimulation member in a first nasal cavity; inserting a second stimulation member in a second nasal cavity; securing the first and second stimulation members such that the stimulation members are in fixed positions within the nasal cavities prior to vibration stimulation; arranging each of the first and second stimulation members to abut against tissue within each of the first and second nasal cavities at a first and second pressure; and imparting vibrations to tissue in at least one of the first and second nasal cavities via at least one of the first and second stimulation members.

The invention discloses a traditional Chinese medicine composition for treating oral ulcer, which belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition for treating oral ulcer is prepared from the following raw materials in parts by weight: 10-12 parts of dandelion, 8-10 parts of alpinia katsumadai, 6-9 parts of radix paeoniae alba, 6-8 parts of poria cocos, 5-7 parts of mint, 5-9 parts of andrographis paniculata, 10-12 parts of fructus aurantii, 10-15 parts of hawthorn, 8-10 parts of radix bupleuri, 10-15 parts of honeysuckle, 7-9 parts of scutellaria baicalensis, 3-6 parts of salvia miltiorrhiza, 5-7 parts of lotus leaves, 5-9 parts of acanthopanax, 3-5 parts of bunge cherry seed and 10-12 parts of liquorice. The traditional Chinese medicine composition is great in treatment effect in the aspect of treating and preventing oral ulcer, and remarkable in clinical promotion value.

The invention discloses a traditional Chinese medicine preparation for treating cholecystitis and gallstones and a preparation method thereof. The main pharmaceutical raw materials and the proportioning by weight are as follows: 18-80 parts of Szechuan lovage rhizome, 18-80 parts of Chinese thorowax, 18-80 parts of costus root, 28-140 parts of yellow croaker ear-stone, 18-80 parts of immature bitter orange, 18-80 parts of officinal magnolia bark, 28-140 parts of Chinese angelica, 18-80 parts of golden thread and 18-80 parts of liquoric root. The preparation method comprises: 1. medicinal materials are washed, wherein, the Chinese angelica is processed with wine, and the yellow croaker ear-stone is calcined; 2. the yellow croaker ear-stone is dried and smashed into medicine powder; 3. the other medicinal materials are dried and smashed into the medicine powder, water is added for soaking, filtrate generated by two times of decoction is merged, an extract is obtained, and the extract is concentrated to thick paste which is further smashed; 4. the medicine powder of the step 2 and the step 3 is mixed; 5. excipients are added for preparing capsules, tablets and so on. The traditional Chinese medicine preparation has significant therapeutic and analgesic effects for cholecystitis and gallstones, obvious efficacy, short treatment cycle and low recurrence rate.